治疗机构年诊疗量与鼻咽癌生存关系
基于美国国家癌症数据库2004—2014年3941例II—IVB期接受根治性放疗的鼻咽癌患者,分析机构年诊疗量与总生存的关系。多因素分析显示高诊疗量机构(前5%)治疗与总生存显著改善相关(HR 0.79,95%CI 0.69-0.90;
要点
- 高诊疗量机构治疗与鼻咽癌总生存改善独立相关(HR 0.79)。
- 匹配后高诊疗量机构5年OS 69.1%,低诊疗量机构63.3%。
核心结论
- 高诊疗量机构治疗与鼻咽癌患者总生存改善相关,且该效应仅见于学术中心。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库2004—2014年II—IVB期接受根治性放疗的鼻咽癌患者,最终纳入3941例、804家机构,中位随访59.4个月;高诊疗量机构定义为年诊疗量前5%的机构。
主要发现
- 机构诊疗量作为连续变量分析时结果相似。
关键数值与推荐
- 高诊疗量机构定义为按年度机构诊疗量排序的前5%机构。
- 纳入标准为2004—2014年诊断的II—IVB期鼻咽癌并接受根治性放疗。
- 排除标准包括分期不完整、治疗接受或时机不明、随访时长不明、社会经济信息不完整或在本报告机构外治疗。
临床怎么用
- 鼻咽癌根治性放疗可优先考虑在高诊疗量机构尤其是学术中心进行,以可能改善总生存。
- 非学术中心的高诊疗量并未显示生存优势,提示机构类型与诊疗量共同影响结局。
局限性
- 为基于国家癌症数据库的回顾性分析,存在未测量混杂的可能。
- 高诊疗量机构仅占极少数(前5%),结果外推需谨慎。
- 疗效差异的具体机制(如放疗技术、多学科协作)未在本文中阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Definitive treatment of nasopharyngeal carcinoma (NPC) is challenging owing to its rarity, complicated regional anatomy, and the intensity of therapy. In contrast to other head and neck cancers, the effect of facility volume has not been well described for NPC. METHODS AND MATERIALS: The National Cancer Database was queried for patients with stage II-IVB NPC diagnosed from 2004 to 2014 and treated with definitive radiation. Patients with incomplete staging, unknown receipt or timing of treatment, unknown follow-up duration, incomplete socioeconomic information, or treatment outside the reporting facility were excluded. High-volume facilities (HVFs) were defined as the top 5% of facilities according to the annual facility volume. RESULTS: The present analysis included 3941 NPC patients treated at 804 facilities with a median follow-up duration of 59.4 months, including 1025 patients (26.0%) treated at HVFs. Treatment at HVFs was associated with significantly improved overall survival (OS) on multivariable analysis (hazard ratio 0.79, 95% confidence interval 0.69-0.90; P=.001). In propensity score-matched cohorts, 5-year OS was 69.1% versus 63.3% at HVFs versus lower volume facilities (LVFs), respectively (P=.003). Similar results were seen when facility volume was analyzed as a continuous variable. The effect of facility volume on survival varied by academic status (P=.002 for interaction). At academic centers, the propensity score-matched cohorts had 5-year OS of 71.4% compared with 62.4% (P<.001) at HVFs and LVFs, respectively. In contrast, the 5-year OS was 63.5% versus 67.9% (P=.68) in propensity score-matched patients at nonacademic HVFs and LVFs. CONCLUSIONS: Treatment at HVFs was associated with improved OS for patients with NPC, with the effect exclusively seen at academic centers.
引用
- Yoshida EJ, Luu M, David JM, et al. Facility Volume and Survival in Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2017. PMID: 29100787. doi:10.1016/j.ijrobp.2017.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。